Organization: Health Canada
Year: 2023
Month: April
Request Number: A-2022-001205
Request Summary: The inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Pharmacovigilance Practices (GVP) re-inspection of the AstraZeneca Canada facility (Site A) on Middlegate Rd, Mississauga, Ontario, with the inspection start date of 05/17/2021. Reference Number 503026.
Disposition: Disclosed in part
Number of pages: 189